Author

Mira Magdy William

Institution: October 6 University

Observed institution: October 6 University

ORCID: 0000-0002-0663-0893

Observed ORCID: 0000-0002-0663-0893

OpenAlex ID: A5009772451

Metformin Loaded Zein Polymeric Nanoparticles to Augment Antitumor Activity against Ehrlich Carcinoma via Activation of AMPK Pathway: D-Optimal Design Optimization, In Vitro Characterization, and In Vivo Study

2024 · Yasmina Elmahboub, Rofida Albash, et al. · Molecules · 35

The potential role of Tirzepatide as adjuvant therapy in countering colistin-induced nephro and neurotoxicity in rats via modulation of PI3K/p-Akt/GSK3-β/NF-kB p65 hub, shielding against oxidative and endoplasmic reticulum stress, and activation of p-CREB/BDNF/TrkB cascade

2024 · Noha F. Hassan, Diaa Ragab, et al. · International Immunopharmacology · 26

Topical loratadine-loaded invasomal gel repurposed for vulvovaginal candidiasis; in vitro, in silico, ex vivo, and in vivo studies

2025 · Inas Essam Ibrahim Al-Samadi, Kareem Omar Rashwan, et al. · International Journal of Pharmaceutics · 7

Amelioration of cyclophosphamide toxicity via modulation of metabolizing enzymes by avocado ( Persea americana) extract

2021 · Tarek Mohamed Kamal Motawi, Mira Magdy William, et al. · Journal of Pharmacy and Pharmacology · 5

Immediate and short-term outcomes of in-hospital canagliflozin initiation in acute heart failure: Results from the CANA-AHF randomized clinical trial

2025 · Rabab A. EL-Gazar, Bassem Zarif, et al. · Heart & Lung · 3

Impact of FOXP1 rs2687201 genetic variant on the susceptibility to HCV‐related hepatocellular carcinoma in Egyptians

2021 · Tarek Mohamed Kamal Motawi, Dina Sabry, et al. · Journal of Biochemical and Molecular Toxicology · 3

Repurposing Niflumic Acid-Loaded PEGylated Cerosomes for Topical Solid Ehrlich’s Carcinoma Management via EGFR/ERK/miR-21 Signaling Pathway Modulation

2026 · Mona M. Mostafa, Shaimaa Mosallam, et al. · Pharmaceutics

Zein-hybrid invasomal sponges as a platform for drug repurposing from migraine to cancer treatment: formulation, optimization, in vitro and in vivo studies

2026 · Radwa M. A. Abd-Elal, Rofida Albash, et al. · RSC Pharmaceutics

Works count: 8

Citation count: 79

H-index: 4

I10-index: 2